Faculty Publications

As of August 2017, this database is no longer being updated. For the most current publications from the faculty, students, and staff of Touro University, please check our institutional repository, Touro Scholar, and email any questions or publication submissions to touro.scholar@touro.edu.

Total number of publications: 7,082

Enter a faculty name:

or browse faculty by school:

Administrative Offices

Graduate Schools

Health Sciences

Lander Colleges

Law Center

New York School of Career and Applied Studies (NYSCAS)

Touro University System

Reset

  • Argo, T., Carnahan, R., Barnett, M. J., Holman, T., & Perry, P. J. (2011). Diabetes prevalence estimates in schizophrenia and risk factor assessment. Annals of Clinical Psychiatry, 23(2), 117-124.

  • Armbruster, J., & Theiss-Abendroth, P. (2016). Deconstructing the myth of Pasewalk: Why Adolf Hitler's psychiatric treatment at the end of World War I bears no relevance. Archives of Clinical Psychiatry, 43(3), 56-9. This material can be found here.

  • Atalayer, D., Gibson, C., Konapacka, A., & Geliebter, A. (2013). Ghrelin and eating disorders. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 40, 70-82. doi:10.1016/j.pnpbp.2012.08.011

    		•

  • Barnett, M. J., VonMuenster, S. J., Wehring, H. J., Walker, V., & Perry, P. J. (2010). Assessment of monitoring for glucose and lipid dysregulation in adult Medi-Cal patients newly started on antipsychotics. Annals of Clinical Psychiatry, 22(1), 9-18. This material can be found here.

  • Childress, A., Belchenko, D., & Lempa, B. (2017). The use of modified-release methylphenidate in the treatment of attention-deficit/hyperactivity disorder. Expert Review of Neurotherapeutics, 17(2), 113-121. doi:10.1080/14737175.2016.1271714

    		•

  • Chou, T. I., & Perry, P. J. (2011). Pharmacotherapy of bipolar depression. California Pharmacist Journal, 58(4), 24-27.

  • Choy, M. (2008). New easier-to-swallow capsule approved to treat bipolar disorder. Drug Topics. This material can be found here.

  • Doroudgar, S., & Chou, T. I. (2014). How to modify psychotropic therapy for patients who have liver dysfunction. Current Psychiatry, 13(12), 46-49. This material can be found here.

  • Doroudgar, S., Chou, T., Yu, J., & Perry, P. J. (2013). Evaluation of trazodone and quetiapine for insomnia: An observational study in psychiatric inpatients. Primary Care Companion for CNS Disorders, 15(6). This material can be found here.

  • English, B. A., Thomas, K. L., Johnstone, J., Bazih, A., Gertsik, L., & Ereshefsky, L. (2014). Use of translational pharmacodynamic biomarkers in early-phase clinical studies for schizophrenia. Biomarkers in Medicine, 8(1), 29-49. doi:10.2217/bmm.13.135

    		•

  • Fish, N. (2011). Nachas ruach: Torah-based psychotherapy and tools for growth and healing. Brooklyn, NY: Targum Press.

  • Haymes, L. K. (2013). [Review of the book The PRT pocket guide: Pivotal response treatment for autism spectrum disorders, by R. Koegel & L. Koegel]. Research and Practice for Persons with Severe Disabilities, 38(1), 63-64.

  • Hopf, F. W., Simms, J. A., Chang, S. J., Seif, T., Bartlett, S. E., & Bonci, A. (2011). Chlorzoxazone, an SK-type potassium channel activator used in humans, reduces excessive alcohol intake in rats. Biological Psychiatry, 69(7), 618-24.

  • Katz, M. B. (2011). A rabbi, a priest, and a psychoanalyst: Religion in the early psychoanalytic case history. Contemporary Jewry, 31(1), 3-24. doi:10.1007/s12397-010-9059-y

    		•

  • Kuperman, S., Calarge, C., Kolar, A., Holman, T., Barnett, M. J., & Perry, P. J. (2011). An open-label trial of aripiprazole in the treatment of aggression in male adolescents diagnosed with conduct disorder. Annals of Clinical Psychiatry, 23(4), 270-276.

  • Perry, P. J., & Wilborn, C. A. (2012). Serotonin syndrome vs. neuroleptic malignant syndrome: A contrast of causes, diagnoses, and management. Annals of Clinical Psychiatry, 24(2), 155-162. This material can be found here.

  • Thomas, K. L., Jiang, Y., & McCombs, J. S. (2015). Clozapine revisited: Impact of clozapine vs olanzapine on health care use by schizophrenia patients on Medicaid. Annals of Clinical Psychiatry, 27(1), e1-e10. This material can be found here.

  • Thomas, K. L., La, A. Q., Punia, S., Doroudgar, S., & Perry, P. J. (2016). Valproic acid-induced hyperammonemia and minimal hepatic encephalopathy prevalence among psychiatric inpatients. Annals of Clinical Psychiatry, 28(1), 37-42. This material can be found here.